Alison J. Foster

1.9k citations

23 papers · 1.1k indexed · h-index 16

Co-authors: J. Gerry Kenna Dominic P. Williams Paul Morgan Brian Middleton Stanley E. Lazic William R. Proctor Mark Pilling Simon Ströbel
Topics: Pharmacogenetics and Drug Metabolism (16 papers)Drug-Induced Hepatotoxicity and Protection (15 papers)Drug Transport and Resistance Mechanisms (8 papers)
Cited by: Pharmacology Hepatology Computational Theory and Mathematics
Journals: Journal of Materials Chemistry Journal of Pharmacology and Experimental Therapeutics Biochemical Pharmacology
Partner nations: United Kingdom Sweden United States

In The Last Decade

Alison J. Foster

22 papers receiving 1.0k citations

Peers

Countries citing papers authored by Alison J. Foster

Since Specialization

Citations

This map shows the geographic impact of Alison J. Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison J. Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison J. Foster more than expected).

Fields of papers citing papers by Alison J. Foster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison J. Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison J. Foster. The network helps show where Alison J. Foster may publish in the future.

Co-authorship network of co-authors of Alison J. Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Alison J. Foster. A scholar is included among the top collaborators of Alison J. Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison J. Foster. Alison J. Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of new approach methodology for hepatic safety assessment of covalent inhibitor drug candidates 2025 ·Toxicology Research ·(unknown),Alison J. Foster,(unknown),(unknown),Stephanie Harlfinger,G. Smith,Jason G. Kettle,(unknown),Stefan Kavanagh,Dominic P. Williams	0
2	Introducing an automated high content confocal imaging approach for Organs-on-Chips 2019 ·Lab on a Chip ·S Peel,Adam Corrigan,Beate Ehrhardt,Kyung‐Jin Jang,Pedro Caetano-Pinto,(unknown),Jonathan E. Rubins,Konstantia Kodella,Debora B. Petropolis,Janey Ronxhi,Gauri Kulkarni,Alison J. Foster,Dominic P. Williams,Geraldine A. Hamilton,Lorna Ewart	73
3	Analysis of β-catenin gene mutations and gene expression in liver tumours of C57BL/10J mice produced by chronic administration of sodium phenobarbital 2019 ·Toxicology ·James E. Sidaway,Terry C. Orton,(unknown),Huw B. Jones,Alison J. Foster,Brian G. Lake	6
4	Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid 2019 ·Archives of Toxicology ·Alison J. Foster,(unknown),Sophie Regan,(unknown),(unknown),Linda C. Andersson,Abhishek Srivastava,Malin Darnell,Jonathan Cairns,Stanley E. Lazic,Kyung‐Jin Jang,Debora B. Petropolis,Konstantia Kodella,Jonathan E. Rubins,Dominic P. Williams,Geraldine A. Hamilton,Lorna Ewart,Paul Morgan	85
5	Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury 2017 ·Archives of Toxicology ·William R. Proctor,Alison J. Foster,Jennifer Vogt,Claire Summers,Brian Middleton,Mark Pilling,(unknown),Monika Kijańska,Simon Ströbel,Jens M. Kelm,Paul Morgan,Simon Messner,Dominic P. Williams	219
6	Cytotoxicity evaluation using cryopreserved primary human hepatocytes in various culture formats 2016 ·Toxicology Letters ·Lysiane Richert,Audrey Baze,C. Parmentier,Helga H.J. Gerets,Rowena Sison‐Young,(unknown),Cerys Lovatt,Andreas Czich,Christopher E. Goldring,B. Kevin Park,Satu Juhila,Alison J. Foster,Dominic P. Williams	18
7	Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acid 2016 ·Toxicology Research ·(unknown),Alison J. Foster,Huw B. Jones,Rhiannon David,Nigel J. Gooderham,Ian D. Wilson,J. Gerry Kenna	1
8	Hepatic effects of repeated oral administration of diclofenac to hepatic cytochrome P450 reductase null (HRN™) and wild-type mice 2015 ·Archives of Toxicology ·(unknown),Alison J. Foster,Ian D. Wilson,Sunil Sarda,Huw B. Jones,J. Gerry Kenna	5
9	Multiple Compound-Related Adverse Properties Contribute to Liver Injury Caused by Endothelin Receptor Antagonists 2014 ·Journal of Pharmacology and Experimental Therapeutics ·J. Gerry Kenna,Simone H. Stahl,(unknown),Alison J. Foster,Linda C. Andersson,(unknown),Martin Billger,Marie Elebring,Charles S. Elmore,Richard A. Thompson	35
10	A comparison of the metabolism of midazolam in C57BL/6J and hepatic reductase null (HRN) mice 2014 ·Biochemical Pharmacology ·(unknown),Alison J. Foster,Richard T. Gallagher,Michael G. Hutchison,Anders Lundqvist,Kathryn Pickup,Ian D. Wilson,Kristin Samuelsson	5
11	Evaluation of the use of imaging parameters for the detection of compound-induced hepatotoxicity in 384-well cultures of HepG2 cells and cryopreserved primary human hepatocytes 2013 ·Toxicology in Vitro ·Helen Garside,(unknown),(unknown),Alison J. Foster,Daniel Muthas,J. Gerry Kenna,Usha Warrior,Joanne Bowes,James E. Baumgartner	74
12	A Correlation Between the In Vitro Drug Toxicity of Drugs to Cell Lines That Express Human P450s and Their Propensity to Cause Liver Injury in Humans 2013 ·Toxicological Sciences ·(unknown),Alison J. Foster,Sunil Sarda,Matthew Bridgland‐Taylor,J. Gerry Kenna	57
13	Glutathione metabolism modeling: A mechanism for liver drug-robustness and a new biomarker strategy 2013 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·(unknown),(unknown),Jacky L. Snoep,Alison J. Foster,Sunil Sarda,J. Gerry Kenna,Ian D. Wilson,Hans V. Westerhoff	30
14	Characterization of THLE-Cytochrome P450 (P450) Cell Lines: Gene Expression Background and Relationship to P450-Enzyme Activity 2012 ·Drug Metabolism and Disposition ·(unknown),Constanze Hilgendorf,(unknown),Alison J. Foster,J. Gerry Kenna,Anne Petersen,Anna‐Lena Ungell	15
15	In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs 2012 ·Chemical Research in Toxicology ·Richard A. Thompson,Emre M. Isin,Yan Li,Lars Weidolf,Ken Page,Ian D. Wilson,Steve Swallow,Brian Middleton,Simone H. Stahl,Alison J. Foster,Hugues Dolgos,Richard Weaver,J. Gerry Kenna	153
16	Bioactivation of the Cannabinoid Receptor Antagonist Rimonabant to a Cytotoxic Iminium Ion Metabolite 2012 ·Chemical Research in Toxicology ·Alison J. Foster,(unknown),(unknown),(unknown),Emre M. Isin,(unknown),Neal Castagnoli,J. Gerry Kenna	17
17	In vitro investigation of the role of cyp dependent metabolism in drug hepatotoxicity using the THLE-CYP cell panel 2010 ·Toxicology ·Alison J. Foster,(unknown),(unknown),(unknown),J. Gerry Kenna	3
18	Systematic tuning of pore morphologies and pore volumes in macroporous materials by freezing 2009 ·Journal of Materials Chemistry ·Lei Qian,Adham Ahmed,Alison J. Foster,Steve P. Rannard,Andrew I. Cooper,Haifei Zhang	49
19	Identification of potent and selective oxytocin antagonists. Part 1: indole and benzofuran derivatives 2002 ·Bioorganic & Medicinal Chemistry Letters ·Paul G. Wyatt,Michael Allen,(unknown),Alison J. Foster,David G. Livermore,(unknown),Jan Scicinski,P.M. Woollard	27
20	The rôle of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective. 1999 ·PubMed ·Christian Cole,Alison J. Foster,Sally Freeman,Mohammed Jaffar,Paul E. Murray,Ian J. Stratford	18

About Alison J. Foster

Alison J. Foster is a scholar working on Pharmacology, Hepatology and Oncology, having authored 23 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (16 papers), Drug-Induced Hepatotoxicity and Protection (15 papers) and Drug Transport and Resistance Mechanisms (8 papers). The work is most often cited by research in Pharmacology (418 citations), Hepatology (239 citations) and Computational Theory and Mathematics (156 citations). Alison J. Foster has collaborated with scholars based in United Kingdom, Sweden and United States. Frequent co-authors include J. Gerry Kenna, Dominic P. Williams, Paul Morgan, Brian Middleton, Stanley E. Lazic, William R. Proctor, Mark Pilling, Simon Ströbel, Jens M. Kelm and Simon Messner. Their work appears in journals such as Journal of Materials Chemistry, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact